Inactive Instrument

William Demant Holding Share Price Nasdaq Copenhagen

Equities

DK0060738599

Medical Equipment, Supplies & Distribution

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 23.26B 3.39B 283B Sales 2025 * 25.05B 3.65B 305B Capitalization 70.93B 10.34B 863B
Net income 2024 * 3.04B 444M 37.05B Net income 2025 * 3.51B 511M 42.69B EV / Sales 2024 * 3.63 x
Net Debt 2024 * 13.44B 1.96B 164B Net Debt 2025 * 13.38B 1.95B 163B EV / Sales 2025 * 3.37 x
P/E ratio 2024 *
23.3 x
P/E ratio 2025 *
19.8 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 39.27%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO 51 01/15/01
Director/Board Member 66 01/92/01
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 58 01/08/01
Director/Board Member 66 01/92/01
Director/Board Member 57 01/21/01
More insiders
Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW